PTD-DBM Dosage Calculator
PTD-DBM (Protein Transduction Domain-fused Dishevelled Binding Motif) is a synthetic peptide developed at Yonsei University that activates the Wnt/β-catenin signaling pathway by competitively disrupting the binding between CXXC5 and Dishevelled (Dvl).
500mcg · Weekly
Summary: Add 0mL BAC water to your 5mg vial. Draw to < 0.1 units on a U-100 syringe for a 500mcg dose. This vial will last 0 doses.
Cycle Planner
PTD-DBM Pharmacokinetics
Pharmacokinetics — Active Dose Over Time
t½ = ~2-4 hours (estimated, topical peptide)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
PTD-DBM Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 500mcg | Weekly |
| Moderate | 1mg | Weekly |
| Aggressive | 1mg | 2x/week |
Note: Topical peptide targeting CXXC5-Dvl interaction. Applied as scalp spray or serum. Often combined with valproic acid and microneedling for synergistic effect. No injection required — topical application only.
About PTD-DBM
PTD-DBM (Protein Transduction Domain-fused Dishevelled Binding Motif) is a synthetic peptide developed at Yonsei University that activates the Wnt/β-catenin signaling pathway by competitively disrupting the binding between CXXC5 and Dishevelled (Dvl). CXXC5 is a zinc finger protein overexpressed in balding scalps that acts as a negative regulator of hair follicle regeneration. By blocking this interaction, PTD-DBM restores Wnt signaling, promoting hair regrowth and wound-induced hair follicle neogenesis. In animal studies, topical PTD-DBM combined with valproic acid produced significant new follicle formation within 28 days.